ClinicalTrials.gg
DrugRead study by study

Entrectinib clinical trials

Also written Rozlytrek, RXDX-101 and RO7102122.

studies test it
32
open now
11
in phase 3
5
first study started
2014
ClinicalTrials.gov finds 47 studies for entrectinib. How that becomes 32 hereChecked on ClinicalTrials.gov

Every study that search finds has been read, to see whether and how it gives entrectinib. Its counts are asked again every night. How drug pages count

  1. 47Found by its intervention search · See all 47 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 41 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. −3
    Mention it without giving it — earlier treatment, a protocol code, a title naming another drug
  3. 44Give entrectinib to participants
  4. −6Observe patients on it, or give it outside a trial
  5. −6Give it beside what is tested
  6. 32Test it: the count on this site

Get an email when these change. Save the entrectinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Aug 2019 · ROZLYTREK · NDA 212725 (FDA, Drugs@FDA)
European Union
31 Jul 2020 · Rozlytrek · EMEA/H/C/004936 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Entrectinib
23

Brand

Rozlytrek
10

Development codes

RXDX-101
5
RO7102122
3
RG6268
1

Studies by the year they started

32 studies that test it; most in 2021 (7)

Studies that test entrectinib, by start year
YearStudies
20141
20152
20163
20172
20194
20204
20217
20222
20233
20251
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
20
Phase 3
5
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 17

Hoffmann-La Roche (9) · Genentech, Inc. (5) · OHSU Knight Cancer Institute (2) · St. Jude Children's Research Hospital (2) · Cancer Research UK (2) · Alliance for Clinical Trials in Oncology (1) · Jules Bordet Institute (1) · Presage Biosciences (1)

Often tested with

Tested in the same studies.

Alectinib (13) · Atezolizumab (9) · Cobimetinib (7) · Vemurafenib (6) · Trastuzumab (6) · Pertuzumab (6) · Olaparib (4) · Niraparib (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 2 in phase 3

Studies that test entrectinib, phase 3 first.

Studies

Open first, then newest update. How each study uses entrectinib has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 32

See all 32 studies that test entrectinib →

Behind its US label · 4 — the studies the FDA label of ROZLYTREK describes

From the Clinical Studies section of ROZLYTREK (2026-10), as openFDA has it. A study the site does not hold is left out.

Tested on its own · 7 — no other medicine in its arm
Tested with established drugs · 1 — they are given beside it
Tested in a combination · 22 — another drug in the study is under test too

Showing 20 of 22. See all 22 →

Beside supportive care · 1 — a supportive treatment or test is studied
One option of several · 5 — a test or a strategy chooses among drugs
Observed · 6 — patients on it are followed, or it is given outside a trial

What changed recently

From the registry's own updates since Oct 19, 2026.

Codes

What other systems call entrectinib · ClinicalTrials.gg INT000452

  • MeSH (NLM) C000607349entrectinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) L5ORF0AN1IENTRECTINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 2197862One source FDA
  • Wikidata Q25323953entrectinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C114984EntrectinibOne source FDA
  • DrugBank DB11986One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion